Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis
about
Esophageal cancer: Recent advances in screening, targeted therapy, and managementPrediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewNonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.Prevention and treatment of cancer with aspirin: where do we stand?A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.Barrett's esophagus: diagnosis and management.Redirecting the focus of cancer immunotherapy to premalignant conditions.From Heartburn to Barrett's Esophagus, and Beyond.Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.
P2860
Q26865552-F7BF77DD-35E4-4465-9A4A-6E3447AFD1EFQ27902278-02CE0938-9868-46E5-B363-B05E90E7195CQ35046884-50E133E5-155A-4B50-B622-672B315B9D5DQ35666515-59891930-EF8B-4ED3-BE1C-731061085C99Q36076749-1BA2B090-DFFB-4F6D-85E8-6B14BF4F1FB4Q37018314-324AAEDB-82C5-461A-873A-773D8460A5A5Q37542809-E747697A-5B0A-417B-89EE-9681AA91D6A7Q37554702-05E6C692-1F71-4092-8154-7CA80AD096DBQ38229399-79636769-EAF1-4E5D-A12C-7E09F50B030AQ38368081-713170E6-7DF4-4636-86E5-F668320F65A3Q39097596-6D0D6B3E-139F-4B3A-82D2-AE88FC6458E3Q39107022-AB32B220-0105-4A7C-A01D-317A1EC92259Q39160690-94411231-1251-4B2C-9BEE-38415BEA77E8Q40522077-7057D780-C3A2-40DA-BB4A-827F278D4909Q49227522-0007D094-1854-4CB6-AEA2-8FC6DEDFC06C
P2860
Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@ast
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@en
Cyclooxygenase inhibitors use ...... 's esophagus: a meta-analysis.
@nl
type
label
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@ast
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@en
Cyclooxygenase inhibitors use ...... 's esophagus: a meta-analysis.
@nl
prefLabel
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@ast
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@en
Cyclooxygenase inhibitors use ...... 's esophagus: a meta-analysis.
@nl
P2093
P2860
P356
P1476
Cyclooxygenase inhibitors use ...... t's esophagus: a meta-analysis
@en
P2093
F Kastelein
P2860
P2888
P304
P356
10.1038/BJC.2014.127
P407
P577
2014-03-20T00:00:00Z
P5875
P6179
1030615781